Follicular Lymphoma — Trials

Follicular Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

775 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 216
Recruiting: 107
Ph III recruiting: 10
Growth YoY: −8.6%
Industry share: 29%
Top sponsor: City of Hope Medical Center
Termination share: 39.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (149)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03817853	An Open-Label, Single Arm Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma	completed	Phase 4	114	Hoffmann-La RocheINDUSTRY	7	Apr 4, 2024	clinicaltrials

Data updated 22 days agoSource updated Apr 4, 2024source: clinicaltrials